Rosen law firm urges biohaven ltd. (nyse: bhvn) stockholders to contact the firm for information about their rights

New york--(business wire)--rosen law firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers of securities of biohaven ltd. (nyse: bhvn) between march 24, 2023 and may 14, 2025. biohaven describes itself as a “biopharmaceutical company that discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology.” for more information, submit a form, email attorney phillip kim, or give us a call at 866-767-3653. the.
BHVN Ratings Summary
BHVN Quant Ranking